Pharmacology Flashcards
(119 cards)
Celecoxib MOA
Indications
Cox-2 inhibitor
less UGI SE compared to Naproxen (inhibits Cox-1 and 2)
OA, RA, AS
How does Celecoxib differ from other NSAIDs?
Celecoxib = Cox-2 inhibitor
NSAIDs e.g. Naproxen inhibit Cox-1 and 2
Cox -1 inhibition affects
COX-1 affects platelet aggregation -> beneficial cardiovascular effects.
However platelet aggregation not affected by COX-2
Ivabradine
MOA?
Use?
Blocks If channel in SAN -> reduced HR
Novel anti-anginal
second line to CCBs e.g. diltiazem and verapamil
Flecainide MOA
Indication
Sodium channel blocker
Anti-arrhythmic used for tachyarrhythmias e.g. AF
Doxazocin
MOA
Uses
Alpha blocker
Tx HTN, also used for LUTs Sx
Spironolactone SE
Gynaecomastia
Inhibits enzymes in testosterone synthesis pathway, and blocks receptor binding of testosterone. Also displaces oestradiol from SHBG so increases free oestrogen levels
SE bisphosphonates
pamidronate /zolendronic acid
Jaw osteonecrosis.
Due to anti-resorptive action of the nitrogen containing bisphosphonates.
SE Lithium
Diabetes insipidus
Hypercalcaemia
Clarithromycin increases concentration/ AUC and risk of toxicity of which COPD drug
theophylline
Clarithromycin + statin risk of
rhabdomyolysis
AntiHTN CI in pregnancy
ACEi
ARB
BB
AntiHTN used in pregnancy
labetolol
methyldopa
2nd line = nifedipine
Selegine
MOA
Indication?
MAO -inhibitor
Selegine used with levodopa in PD
Analgesic that increases lithium concentration (by decreasing renal clearance)
Diclofenac
St John's wort Carbamazepine Phenobarbitone Rifampicin Phenytoin
effect on warfarin
decreases warfarin conc
as both are CYP450 inducer
ABx causing achilles tendon rupture
Fluoroquinolones
- floxacins
e. g ciprofloxacins
Adalimumab MOA
TNF-a inhibitor
Binds human TNFa and stops it binding to receptors -> reduces inflammation
in e.g. psoriasis
Why use metformin in PCOS
Increases insulin sensitivity / PERIPHERAL GLUCOSE UPTAKE
(insulin resistance in PCOS)
this -> ovulation in increased chances of CONCEPTION
Drug that can improve outcomes in severe sepsis
LOW DOSE steroids (hydrocortisone)
Ertolinib for e.g. pancreatic Ca
MOA
mechanism of resistance
MOA - targets epidermal growth factor (EGFR) tyrosine kinase + ATP binding -> cell signalling
Resistance after 1 year as mutation in ATP binding site
Causes QT shortening
Electrolytes
Endocrine
Drugs
High Ca, High Mg
Thyrotoxicosis
DIGOXIN
Dopamine effect on prolactin
inhibits prolactin from anterior pituitary
Drugs that increase prolactin levels
Antipsychotics e.g. Risperidone
APs = DA receptor antagonists therefore less DA therefore higher prolactin